Literature DB >> 18760756

B-type natriuretic peptide: beyond a diagnostic.

Fernando L Martin1, Horng H Chen, Alessandro Cataliotti, John C Burnett.   

Abstract

The concept of the heart as an endocrine organ has been attractive since the discovery of atrial natriuretic peptide. This review focuses on the second discovered natriuretic peptide from the heart - B-type natriuretic peptide (BNP), widely used as a tool in the diagnosis of heart failure (HF). Controversy remains regarding its use as a therapeutic agent in HF. This article places into perspective some of the debate and provides insights into the therapeutics of BNP and the importance of its second messenger 3'5' cyclic guanosine monophosphate, which also is the second messenger for nitric oxide and is modulated by renal phosphodiesterases.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18760756      PMCID： PMC4601805          DOI： 10.1016/j.hfc.2008.03.011

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  33 in total

1.  Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.

Authors:  Henry G Riter; Margaret M Redfield; John C Burnett; Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2006-05-16       Impact factor: 24.094

2.  Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP.

Authors:  S W John; A T Veress; U Honrath; C K Chong; L Peng; O Smithies; H Sonnenberg
Journal:  Am J Physiol       Date:  1996-07

3.  Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure.

Authors:  Gurminder Singh; Rhoda E Kuc; Janet J Maguire; Mark Fidock; Anthony P Davenport
Journal:  Circ Res       Date:  2006-06-15       Impact factor: 17.367

4.  Gene and precursor structures of human C-type natriuretic peptide.

Authors:  Y Tawaragi; K Fuchimura; S Tanaka; N Minamino; K Kangawa; H Matsuo
Journal:  Biochem Biophys Res Commun       Date:  1991-03-15       Impact factor: 3.575

Review 5.  Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.

Authors:  Rodolphe Fischmeister; Liliana R V Castro; Aniella Abi-Gerges; Francesca Rochais; Jonas Jurevicius; Jérôme Leroy; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2006-10-13       Impact factor: 17.367

6.  Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans.

Authors:  K T Jensen; J Carstens; E B Pedersen
Journal:  Am J Physiol       Date:  1998-01

7.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase.

Authors:  E G Shesely; N Maeda; H S Kim; K M Desai; J H Krege; V E Laubach; P A Sherman; W C Sessa; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

8.  Bioactivity and metabolism of C-type natriuretic peptide in normal man.

Authors:  P J Hunt; A M Richards; E A Espiner; M G Nicholls; T G Yandle
Journal:  J Clin Endocrinol Metab       Date:  1994-06       Impact factor: 5.958

9.  C-type natriuretic peptide (CNP) in rats and humans.

Authors:  Y Komatsu; K Nakao; S Suga; Y Ogawa; M Mukoyama; H Arai; G Shirakami; K Hosoda; O Nakagawa; N Hama
Journal:  Endocrinology       Date:  1991-08       Impact factor: 4.736

10.  C-type natriuretic peptide: a selective cardiovascular peptide.

Authors:  A L Clavell; A J Stingo; C M Wei; D M Heublein; J C Burnett
Journal:  Am J Physiol       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.